Form 8-K - Current report:
SEC Accession No. 0000886163-22-000137
Filing Date
2022-12-05
Accepted
2022-12-05 07:03:49
Documents
12
Period of Report
2022-12-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K lgnd-20221205.htm   iXBRL 8-K 36711
  Complete submission text file 0000886163-22-000137.txt   173335

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20221205.xsd EX-101.SCH 1909
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20221205_lab.xml EX-101.LAB 24132
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20221205_pre.xml EX-101.PRE 12516
6 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20221205_htm.xml XML 10864
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 221443728
SIC: 2834 Pharmaceutical Preparations